Soraya Camargo Ito Süffert

Soraya Camargo Ito Süffert

Auto-generated profile, based on publicly available information

Soraya Camargo Ito Süffert

Federal University of Health Sciences of Porto Alegre (UFCSPA)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
EAEmanuelle Roberta da Silva Aquino
Emanuelle Roberta da Silva Aquino
SSSoraya Camargo Ito Suffert
Soraya Camargo Ito Suffert
Background: Telemedicine develops from technology that offers opportunities for knowledge transfer and information sharing and allows the provision of health services at a distance. Objective: To evaluate the number of publications on teleneurology in the last two decades in PubMed and the available evidence on the use of this technology in neurological clinical conditions. Methods: A quantitative assessment of publications related to telemedicine and neurology in the last two decades. A search was performed on the PubMed database for the descriptors ("Telemedicine"[Mesh]) AND "Neurology"[Mesh]). A review of the articles retrieved on the topic was carried out to evaluate the innovation processes used and applications in various clinical conditions involving teleneurology. Results: The search performed on March 14th 2022 resulted in 229 publications involving the topic of telemedicine and neurology between 1999 and 2022. Since 2000, there has been an increase in publications related to this topic, with a peak of 71 articles published in 2020, the year in which the World Health Organization defined the COVID-19 pandemic status. Conclusion: In the last two decades, teleneurology has been developing through the expansion of technological resources and the COVID-19 pandemic intensified this process. Different modalities of teleneurology are studied in several neurology subfields and include teleconsultation (between healthcare professionals or between healthcare professionals and patients), telerehabilitation, telemonitoring and tele-education. The advances achieved by teleneurology in this period encouraged technological innovations and health processes that developed opportunities to improve the care provided in a mechanism of constant evolution.

21 November 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
EAEmanuelle Roberta da Silva Aquino
Emanuelle Roberta da Silva Aquino
DRDaniela Laranja Gomes Rodrigues
Daniela Laranja Gomes Rodrigues
CBCarlos Eduardo Alves Batista
Carlos Eduardo Alves Batista
JBJosue Basso
Josue Basso
SGSabrina Dalbosco Gadenz
Sabrina Dalbosco Gadenz
CMCarlos Eduardo Mantese
Carlos Eduardo Mantese
OBJECTIVE: This study aimed to characterize teleconsultations in neurology executed by Regula+Brasil project in Recife, a capital city in northeastern Brazil. METHODS: A descriptive study carried out by four private hospitals, in a partnership with the Ministry of Health in Brazil. Teleconsultation was performed preferably in the video modality. Conditions eligible for teleconsultation were headache, epilepsy, and cerebrovascular disorders. Period of analysis was May to September 2020. RESULTS: A total of 243 teleconsultations were analyzed, of which 76.95% was a first appointment. In 48.97% of cases, the teleconsultation represented the first opportunity for the patient to be consulted with the specialist. Among cases of first appointment, 20.16% were further referred to a face-to-face consultation and 21.81% could be redirected to primary health care. Headache disorders were the most predominant clinical conditions. CONCLUSIONS: The implementation and development of telemedicine by Regula+Brasil during the COVID-19 pandemic represented an opportunity to assess the value of having teleconsultations added along the line of care from primary care to a medical specialty, promoting the coordination of care across different levels of complexity of care in the health system and improving access to specialized care. KEYWORDS: Neurology. Referrals and consultation. Effective access to health services. Public Health.

8 May 2025 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Closed access
RTRaquel Prado Thomaz
Raquel Prado Thomaz
MMMônica Rossatti Molina
Mônica Rossatti Molina
BLBruno Belo Lima
Bruno Belo Lima
DFDesireé Souza Filizzola
Desireé Souza Filizzola
MGMariana Setanni Grecco
Mariana Setanni Grecco
SSSoraya Camargo Ito Süffert
Soraya Camargo Ito Süffert
Objective: To describe the process of conception and articulation of the Care Pathways in Palliative Care in Primary Health Care in the locations served by BP’s TeleNordeste project in the interior of the Brazilian Northeast. Methods: Experience report on the process of designing and articulating Care Pathways in Palliative Care for regions far from urban centers in 3 states in Brazil: Alagoas, Maranhão and Piauí, through the TeleNordeste Project of Hospital Beneficência Portuguesa in São Paulo through the Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde (SUS) in the 2021-2023 period. After pre-operational alignments with health representatives, processes were defined and training was carried out for local teams on the flows and modalities of care available through telehealth, connecting the patient, doctor from the Basic Health Unit and palliative doctor to establish a care plan timely to the needs of patients. Results: A total 178 teleconsultations were carried out in the specialty of Palliative Care, 124 (69.7%) were teleinterconsultations and 54 (30.3%) were teleconsulting. The median age was 75 years with an interquartile range of 16. Approximately 74,699 miles and 1845 hours of patient time in palliative care were saved. Approximately 29,880 kg of CO2 emissions were avoided. Discussion: The development of Care Pathways presented an innovative proposal for access to specialized Palliative Care in the SUS, considering the sustainability of the health system and promoting better equity in access to palliative care for regions far from reference centers.

21 December 2021 in Saúde em Redes
Verified
Journal Article
Closed access
PDF file
SSSoraya Camargo Ito Süffert
Soraya Camargo Ito Süffert
RTRaquel Prado Thomaz
Raquel Prado Thomaz
LCLuciana Campos
Luciana Campos
EGEduardo Correa Gomes
Eduardo Correa Gomes
TRTiago Almeida Ramos
Tiago Almeida Ramos
MFMarcelo Fagundes
Marcelo Fagundes
Introdução: o aumento da expectativa de vida da população brasileira associada a maior prevalência de doenças crônicas não transmissíveis promovem uma maior demanda de recursos assistenciais em saúde, dentre eles os cuidados paliativos (CP). Um serviço hospitalar de Cuidados Paliativos melhora os desfechos em saúde dos pacientes internados e facilita a discussão acerca dos valores dos pacientes, diagnóstico, prognóstico da doença e concordância sobre os objetivos do plano de cuidados, com evidências da redução de indicações de tratamentos não benéficos e até mesmo prejudiciais no final de vida. Metodologia: relato de experiência da implementação das Linhas de Cuidados, para Cuidados Paliativos em hospital de retaguarda clínica e longa permanência de Porto Alegre, utilizando a proposta metodológica de Rosique estruturada em quatro etapas: seleção, desenvolvimento, implementação e avaliação/monitoramento de qualidade. Este processo foi realizado no período de outubro de 2018 a maio de 2019 para organização dos fluxos assistenciais e monitoramento da qualidade. Resultados: obtivemos um planejamento estruturado, com ações estratégicas para implementar os Cuidados Paliativos. Os resultados são descritos nos fluxogramas assistenciais. A construção das LC facilitou a comunicação, coordenação de papéis, organização das atividades da equipe multidisciplinar de atendimento, o adequado registro, monitoramento, avaliação de variações, de resultados, indicadores de desfechos e identificação dos recursos apropriados. Conclusão: este processo qualificou a assistência com a capacitação dos recursos humanos, estabeleceu recursos tecnológicos disponíveis e materiais essenciais, possibilitou o desenvolvimento de protocolos e foi possível instituir indicadores para monitorar a qualidade da assistência aos pacientes e suas famílias.

23 December 2022 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Closed access
SSSoraya C. Ito Suffert
Soraya C. Ito Suffert
BMBruna B. Motke
Bruna B. Motke
ALArmani B. Linhares
Armani B. Linhares
AVAndré F. Vargens
André F. Vargens
TATainá S. Alano
Tainá S. Alano
RARafael José Vargas Alves
Rafael José Vargas Alves
Background: An estimated 9.6 million people died from cancer globally in 2018, which is a reflection of the quality of patients’ end-of-life care and its costs. Aim: To estimate direct medical costs of the last 30 days of oncology patients admitted to an inpatient clinic and to evaluate factors associated with medical costs at the end of life. Design: Cost-of-illness study with data from a retrospective cohort. Setting/Participants: We included patients aged 18 and older who were diagnosed with incurable cancer and who were admitted to a tertiary hospital in Brazil between January 1, 2018 and December 31, 2019. Results: Our sample included 109 patients with an average age of 69 (61‒76). The median overall survival was 4.3 (.9‒12.9) months. The median cost per patient per day related to hospitalization was BRL 119 (73‒181)/United States dollars [USD] 21 (13‒33). The cost of medication was BRL 66 (40‒105)/USD 12 (7‒19), representing 55.46% of costs while that of materials and supplies was BRL 30 (18‒49)/USD 5 (3‒9). In the multivariate analysis, when the limitation of interventions was recorded in the medical record, the median cost is reduced by BRL 50 (USD 9) per patient per day. Conclusions: The median cost per patient per day was BRL 119 (73‒181). The recording of limitations of therapeutic interventions in the medical record was a predictor variable that influenced the final medical cost of patients, suggesting that medical practice and decision-making in end-of-life care impact costs.

23 September 2024 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Closed access
SSSoraya Camargo Ito Süffert
Soraya Camargo Ito Süffert
CMCarlos Eduardo Aliatti Mantese
Carlos Eduardo Aliatti Mantese
FMFelipe Rodrigo de Castro Meira
Felipe Rodrigo de Castro Meira
KTKatia Flavia Rosso de Oliveira Trindade
Katia Flavia Rosso de Oliveira Trindade
Ana Paula Beck da Silva EtgesAna Paula Beck da Silva Etges
Ana Paula Beck da Silva Etges
CBClaudia Bica
Claudia Bica
Objectives: Identify the costs of an oncology patient at the end of life. Methods: A systematic literature review was conducted by screening Embase, PubMed and Lilacs databases, including all studies evaluating end-of-life care costs for cancer patients up to March 2024. The review writing followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The quality of the included studies was assessed using the Drummond checklist. The protocol is available at PROSPERO CRD42023403186. Results: A total of 733 studies were retrieved, and 43 were considered eligible. Among the studies analyzed, 41,86% included all types of neoplasms, 18.60% of lung neoplasm, All articles performed direct cost analysis, and 9.30% also performed indirect cost analysis. No study evaluated intangible costs, and most presented the macrocosting methodology from the payer’s perspective. The articles included in this review presented significant heterogeneity related to populations, diagnoses, periods considered for evaluation of end-of-life care, and cost analyses. Most of the studies were from a payer perspective (74,41%) and based on macrocosting methodologies (81,39%), which limit the use of the information to evaluate variabilities in the consumption of resources. Conclusions: Considering the complexity of end-of-life care and the need for consistent data on costs in this period, new studies, mainly in low- and middle-income countries with approaches to indirect and intangible costs, with a societal perspective, are important for public policies of health in accordance with the trend of transforming value-based care, allowing the health care system to create more value for patients and their families.